Repeated Intratumoral Administration of ONCOS-102 Leads to Systemic Antitumor CD8+T-cell Response and Robust Cellular and Transcriptional Immune Activation at Tumor Site in a Patient With Ovarian Cancer

OncoImmunology - United States
doi 10.1080/2162402x.2015.1017702
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer

Frontiers in Immunology
AllergyImmunology
2018English

Frequency Determination of Breast Tumor-Reactive CD4 and CD8 T Cells in Humans: Unveiling the Antitumor Immune Response

OncoImmunology
OncologyAllergyImmunology
2019English

P2.04-04 Expression of Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD4+T Cell, CD8+T Cell and FOXP3+T Cell in Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Robust Iterative Stimulation With Self-Antigens Overcomes CD8+ T Cell Tolerance to Self- And Tumor Antigens

Cell Reports
BiochemistryGeneticsMolecular Biology
2019English

Precise Spatio-Temporal Interruption of Regulatory T Cell-Mediated CD8+ T Cell Suppression Leads to Tumor Immunity

Cancer Research
Cancer ResearchOncology
2018English

Recruitment of Latent Pools of High-Avidity CD8+T Cells to the Antitumor Immune Response

Journal of Experimental Medicine
MedicineAllergyImmunology
2005English

Systemic Monocyte and T-Cell Activation in a Patient With Human Parvovirus B19 Infection

Mayo Clinic Proceedings
Medicine
1995English

Immune Evasion of Mantle Cell Lymphoma: Expression of B7-H1 Leads to Inhibited T-Cell Response to and Killing of Tumor Cells

Haematologica
Hematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy